Therapeutic MUC1-Based Cancer Vaccine Expressed in Flagella-Efficacy in an Aggressive Model of Breast Cancer

World Journal of Vaccines
doi 10.4236/wjv.2012.23015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scientific Research Publishing, Inc,

Related search

Design of a MUC1-based Cancer Vaccine

Biochemical Society Transactions
Biochemistry
2005English

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

2018English

Vaccine Against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon Cancer

Cancer Prevention Research
MedicineCancer ResearchOncology
2010English

Claudin-20 Promotes an Aggressive Phenotype in Human Breast Cancer Cells

Tissue Barriers
BiochemistryHistologyCell Biology
2013English

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model

Cancer Research
Cancer ResearchOncology
2011English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Pathology
Forensic MedicinePathology
2020English

Increased Efficacy of a Dendritic Cell–based Therapeutic Cancer Vaccine With Adenosine Receptor Antagonist and CD73 Inhibitor

Tumor Biology
MedicineCancer Research
2017English

An in Silico Chimeric Vaccine Targeting Breast Cancer Containing Inherent Adjuvant

Iranian Journal of Cancer Prevention
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy